深圳市真兴医药技术有限公司

At 11:30 am on December 27, 2019, the signing ceremony of "Strategic Cooperation Framework Agreement" of Zhenxing Pharmaceutical, Fangdexin Fund and Corun Holdings was successfully held on the 41st floor of China Energy Storage Building.

This marks that the three parties, on the basis of friendly consultation, have reached consensus on sincere cooperation and win-win development and formed strategic cooperative partners with complementary strengths and joint efforts. Jianwu Cheng, President of Zhenxing Pharmaceutical, Zhong Liang, chairman of Fangdexin Fund, and Faping Zhong, chairman of Corun Holdings, delivered speeches at the signing ceremony successively:

Cheng Jianwu, President of Zhenxing Pharmaceutical, said that with the help of funds and resources of Fangdexin Fund and Corun Holdings, we will do a good job in the company's r&d project deployment with a serious and pragmatic attitude.

With the increasing support from the registration system, the science innovation board and the main board of Hong Kong financial markets for THE IPO of r&d biomedical enterprises, Zhenxing Pharmaceutical will actively promote the IPO listing as planned, so as to realize the vision of serving the society and rewarding shareholders. Never forget the original intention and benefit mankind, the company will be built into a sustainable development of the domestic oncology new drug research and development of first-class enterprises.

Zhong Liang, chairman of Fangdexin Fund, said that he was very glad to have the opportunity to study and struggle together with such passionate and dreamlike companies as Zhenxing Pharmaceutical and Corun Holdings.

This is the worst of times, this is the best of times.

This is because the country is at a crucial stage in its history when new drivers of growth are being replaced by new ones. For the old and backward industries, it is the worst time, because they will be eliminated. For new industries, especially the biomedical industry in which Zhenxing operates, these are the best of times, because they represent opportunity and hope.

Fangdexin Fund invests in high-tech field for a long time and sticks to the investment concept of "capital service industry". It is willing to dance together with Zhenxing Medicine founded by Mr. Cheng Liren and Corun founded by Chairman Faping Zhong in this era and make due contributions to the country and nation. I am also willing to work with Corun to plug in the wings of capital and big data for Zhenxing Medicine, so that Zhenxing Medicine company can bring benefits to the nation as soon as possible and soar in the sky!

Faping Zhong, chairman of Corun holdings, said corun has a number of industrial entities including listed companies and has rich public resources at provincial, municipal and national levels. In terms of international and domestic high-end medical talents, there are resource reserves, and there are successful cases of national project application and implementation in Shenzhen.

科Corun will make full use of its advantages to provide resources and capital support for the development of Zhenxing Medicine. The enterprise must seek the science and technology innovation only then has the sustainable development motive force, will certainly with The True xing medicine, the Fang DE letter fund, the unity cooperation, does not dishonor the mission, the common cause!

At the signing of the strategic Framework agreement, the three parties agreed to adhere to the spirit of "reform and opening up" and integrate production factors in multiple fields, including biomedical technology, financial capital and resources, big data and intelligent innovation, so as to achieve complementary advantages, win-win cooperation and coordinated development. We will adhere to the grand plan of making contributions to the country and the nation and bringing benefits to mankind, and forge ahead with unity and perseverance.

This signing ceremony is an important milestone for the future development of the three companies!